Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 USD | -9.98% | -58.68% | -69.95% |
Apr. 30 | Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.95% | 67.28M | |
-1.61% | 104B | |
+6.82% | 97.47B | |
+5.71% | 22.25B | |
-12.70% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.32% | 16.36B | |
+7.29% | 14.39B | |
+37.72% | 12.37B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Brookline Capital Starts Annovis Bio at Buy With $35 Price Target